Support for use of psilocybin in medical trials and treatment U.S. 2017, by age
This statistic shows the percentage of U.S. adults who supported allowing researchers to conduct medical trials with psilocybin as of 2017, by age. According to the survey, 65 percent of respondents aged between 18 and 34 years supported the use of psilocybin in medical trials.